Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?
Joint Authors
Source
Hepatitis Research and Treatment
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-09-21
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
More than 350 million people worldwide are persistently infected with human heptatitis B virus (HBV) and at risk to develop liver cirrhosis and hepatocellular carcinoma making long-term treatment necessary.
While a vaccine is available and new antiviral drugs are being developed, elimination of persistently infected cells is still a major issue.
Recent efforts in adoptive cell therapy are experimentally exploring immunotherapeutic elimination of HBV-infected cells by means of a biological attack with genetically engineered “designer” T cells.
American Psychological Association (APA)
Protzer, U.& Abken, Hinrich. 2010. Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?. Hepatitis Research and Treatment،Vol. 2010, no. 2010, pp.1-9.
https://search.emarefa.net/detail/BIM-506522
Modern Language Association (MLA)
Protzer, U.& Abken, Hinrich. Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?. Hepatitis Research and Treatment No. 2010 (2010), pp.1-9.
https://search.emarefa.net/detail/BIM-506522
American Medical Association (AMA)
Protzer, U.& Abken, Hinrich. Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?. Hepatitis Research and Treatment. 2010. Vol. 2010, no. 2010, pp.1-9.
https://search.emarefa.net/detail/BIM-506522
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-506522
